Replies to post #11809 on Biotech Values

[io_io]

"...ATryn trials test individuals with HD who undergo elective surgery or childbirth."

Huh ?

Well, if so, will the approved indication that they are seeking be confined to this class of individuals ? And if so, why so narrow a class ? (almost a "sub-group" !?)